The THBD Gene Hemolytic Uremic Syndrome Genetic Test is a specific diagnostic tool available at DNA Labs UAE, designed to identify mutations in the THBD gene, which are associated with an increased risk of developing Hemolytic Uremic Syndrome (HUS). HUS is a rare but severe condition characterized by the triad of acute renal failure, microangiopathic hemolytic anemia, and thrombocytopenia. This condition often arises following an infection, particularly by certain strains of E. coli, but when linked to genetic factors like mutations in the THBD gene, it can present without a preceding infection, leading to atypical HUS.
The test, priced at 4400 AED, involves collecting a DNA sample, typically through a blood draw, which is then analyzed in the laboratory to detect any genetic anomalies in the THBD gene. The outcome of this test can significantly influence the management and treatment plan for individuals at risk of or presenting with symptoms of HUS. Early detection through genetic testing allows for timely intervention, potentially mitigating severe complications associated with the disease. DNA Labs UAE offers this specialized genetic test as part of its comprehensive suite of diagnostic services, employing state-of-the-art technology and expertise to ensure accurate and reliable results.
The CD46 Gene Hemolytic Uremic Syndrome (aHUS) Atypical Type 2 Susceptibility genetic test is a specialized diagnostic tool offered by DNA Labs UAE, aimed at detecting mutations in the CD46 gene. These mutations are associated with an increased risk of developing Atypical Hemolytic Uremic Syndrome Type 2, a rare, life-threatening genetic disorder. aHUS leads to the abnormal destruction of red blood cells, reduced blood flow to organs, and kidney failure due to the formation of blood clots in small blood vessels. The CD46 gene plays a crucial role in regulating the immune system's complement pathway, which, when dysregulated, contributes to the development of aHUS.
The test is priced at 4400 AED and is designed for individuals who may be at risk of this condition, either due to a family history or presenting symptoms suggestive of aHUS. Early detection through this genetic test can be crucial for the timely management and treatment of the condition, potentially preventing its progression and associated complications. DNA Labs UAE provides this testing service with a focus on accuracy, confidentiality, and support for patients and their families navigating the implications of genetic risk factors for aHUS.
The "SCO1 Gene Hepatic Failure Early Onset and Neurologic Disorder Genetic Test" is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the SCO1 gene. This gene plays a crucial role in the proper functioning of the human body, and mutations can lead to severe conditions characterized by early onset hepatic failure and neurological disorders. The test aims to provide essential genetic information that can assist in the diagnosis, management, and treatment planning for affected individuals. With a cost of 4400 AED, the test is a valuable tool for families and individuals at risk, offering insights that can lead to timely interventions and potentially improved outcomes.
The SP110 Gene Hepatic Venoocclusive Disease with Immunodeficiency Genetic Test is a sophisticated diagnostic assessment offered by DNA Labs UAE, designed to detect mutations in the SP110 gene. These mutations are linked to Hepatic Veno-occlusive Disease with Immunodeficiency (VODI), a rare genetic disorder characterized by liver disease and a weakened immune system. This condition often presents challenges in diagnosis due to its complex symptoms, making the genetic test a crucial tool for accurate diagnosis.
The test involves collecting a DNA sample from the patient, usually through a blood draw, which is then analyzed in the laboratory for any abnormalities in the SP110 gene. Identifying mutations in this gene can confirm the diagnosis of VODI, allowing healthcare providers to tailor a treatment plan suited to the patient's specific needs.
The cost of the SP110 Gene Hepatic Venoocclusive Disease with Immunodeficiency Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the specialized nature of the test, the advanced technology used in the analysis, and the professional expertise required to interpret the results. For families and individuals facing the possibility of VODI, this test provides a vital resource for obtaining a definitive diagnosis and beginning the path to appropriate management and care.
The KCNJ5 gene hyperaldosteronism type 3 genetic test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to identify mutations in the KCNJ5 gene, which can lead to a condition known as familial hyperaldosteronism type III. This condition is characterized by the overproduction of the hormone aldosterone by the adrenal glands, leading to high blood pressure and low levels of potassium in the blood. Early detection through this genetic test is crucial for the effective management and treatment of the condition, helping to prevent potential complications such as cardiovascular disease. The test is priced at 4400 AED and is conducted using state-of-the-art genetic sequencing technologies to ensure accurate and reliable results.
The F13A1 gene plays a crucial role in the final stage of the blood clotting process by encoding the coagulation factor XIII A chain, essential for wound healing and preventing excessive bleeding. A deficiency in this factor, due to mutations in the F13A1 gene, can lead to a rare bleeding disorder characterized by a tendency to bleed excessively after surgery or injury and, in some cases, spontaneous bleeding. To diagnose this condition, a genetic test targeting the F13A1 gene can be conducted.
DNA Labs UAE offers a comprehensive genetic test for Factor XIIIA deficiency, aimed at individuals who have a clinical history suggestive of a bleeding disorder or those with a family history of the condition. This test is particularly crucial for accurate diagnosis and subsequent management of the disorder, including preventive measures for bleeding episodes and tailored treatment plans.
The cost of the F13A1 Gene Factor XIIIA Deficiency Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the meticulous process of analyzing the F13A1 gene for mutations that could lead to Factor XIIIA deficiency. By opting for this test, patients and healthcare providers can make informed decisions regarding the management of the condition, potentially improving the quality of life for those affected.
The SLC34A1 gene plays a crucial role in phosphate transport in the kidneys, and mutations in this gene can lead to Fanconi Renotubular Syndrome Type 2 (FRTS2). This condition is characterized by impaired kidney function, leading to issues with mineral and electrolyte balance. The genetic test for the SLC34A1 gene mutation is a critical tool in diagnosing FRTS2, enabling healthcare providers to tailor treatment and management strategies for affected individuals.
At DNA Labs UAE, the genetic test for the SLC34A1 mutation associated with Fanconi Renotubular Syndrome Type 2 is available. The cost of the test is 4400 AED. This test is conducted using advanced genetic sequencing technologies to accurately identify mutations in the SLC34A1 gene. By opting for this test, patients and their families can gain valuable insights into their genetic predisposition to FRTS2, allowing for early intervention and better management of the condition.
The SLC2A2 gene Fanconi-Bickel syndrome genetic test is a specialized diagnostic procedure designed to identify mutations in the SLC2A2 gene, which are responsible for causing Fanconi-Bickel syndrome (FBS). This rare genetic disorder affects the body's ability to properly metabolize and use carbohydrates, leading to a range of symptoms including kidney problems, impaired growth, and rickets. The test involves analyzing the patient's DNA to pinpoint any genetic anomalies in the SLC2A2 gene that might be indicative of the syndrome.
Conducted at DNA Labs UAE, a leading facility in genetic testing and diagnostics, this test offers a crucial means for early detection and management of Fanconi-Bickel syndrome. With a cost of 4400 AED, it provides a comprehensive assessment, enabling healthcare providers to devise appropriate treatment plans and offer genetic counseling based on the results. This test is particularly recommended for individuals showing symptoms of FBS or those with a family history of the condition, aiming to ensure accurate diagnosis and optimal care.
The MT-TY gene is implicated in various genetic conditions, including focal segmental glomerulosclerosis (FSGS) and dilated cardiomyopathy (DCM), both of which are serious health issues affecting the kidneys and the heart, respectively. FSGS is a disease where scar tissue develops on the parts of the kidneys that filter waste from the blood, while DCM involves the enlargement and weakening of the heart muscle, leading to reduced heart function.
DNA Labs UAE offers a specialized genetic test targeting the MT-TY gene to identify mutations that may predispose individuals to FSGS and DCM. This test is a crucial tool for early diagnosis and management of these conditions, allowing for tailored treatment plans that can significantly improve patient outcomes.
The test is priced at 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the MT-TY gene. Conducted in state-of-the-art facilities, the test provides a comprehensive genetic analysis, offering valuable insights for patients and their families. By choosing to undergo this genetic testing at DNA Labs UAE, individuals gain access to crucial information that can guide healthcare decisions and potentially prevent the progression of FSGS and DCM.
The ACTN4 Gene Focal Segmental Glomerulosclerosis Type 1 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to detect mutations in the ACTN4 gene, which are implicated in the development of Focal Segmental Glomerulosclerosis Type 1 (FSGS Type 1). FSGS Type 1 is a rare and severe form of kidney disease that affects the glomeruli, the filtering units of the kidney, leading to significant proteinuria and potentially progressing to kidney failure.
This genetic test is crucial for individuals who have a family history of FSGS or exhibit symptoms indicative of the disease, as it allows for an accurate diagnosis, guiding treatment decisions and genetic counseling. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed for specific mutations in the ACTN4 gene known to cause FSGS Type 1.
The cost of the ACTN4 Gene Focal Segmental Glomerulosclerosis Type 1 Genetic Test at DNA Labs UAE is 4400 AED. This investment in health can provide critical insights for affected individuals and their families, facilitating early intervention strategies and personalized management plans to mitigate the progression of the disease and improve quality of life.
